【目的】克隆和表达了日本血吸虫CyclophilinA(SjCyPA)编码基因cDNA,分析其在日本血吸虫不同发育阶段虫体的表达情况,评估该重组抗原在小鼠体内诱导的抗血吸虫免疫保护效果。【方法】从实验室构建的7天童虫消减cDNA文库中,PCR扩增-EST序列的基因全长cDNA,提交到NCBI,登录号为GQ403666。应用荧光实时定量PCR分析该基因在日本血吸虫不同发育阶段虫体的表达情况,以pET28a(+)为载体构建重组表达质粒,并在大肠杆菌中表达。诱导、表达、纯化和复性重组蛋白,测定其PPIase活性。利用Western blot检测重组蛋白的抗原性。以重组抗原免疫小鼠,评估其对小鼠诱导的免疫保护效果。【结果】PCR获得了sjCyPA编码基因的全长cDNA,其开放阅读框为519bp。荧光实时定量PCR分析表明,该基因在13d童虫表达量最高,为童虫期高表达基因。构建了重组表达质粒pET28a(+)-SjCyPA,并在大肠杆菌中成功表达。复性重组蛋白具有PPIase活性。Westernblot试验显示该重组蛋白具有良好的抗原性,在小鼠免疫试验中,与空白对照组比较,免疫组小鼠获得18.72%的减虫率和44.6%的肝脏减卵率。【结论】获得了日本血吸虫童虫期高表达的sjCyPA基因的全长cDNA,成功构建了彤CyPA原核重组表达质粒,在大肠杆菌中成功表达,纯化复性得到有PPIase活性的彤CyPA重组蛋白,并证实该重组抗原在小鼠体内诱导产生了部分免疫保护效果。
[Objective] The present study was intended to clone a cDNA encoding cyclophilin A in Schistosomajaponicum and subsequently investigate its molecular functions as well as immunoprotective potential as a vaccine candidate for schistosomasis [Method] Polymerase chain reaction (PCR) technique was employed to amplify the full-length cDNA encoding cyclophilin A of schistosomula (Sj CyPA) by employing a schistosomula specific enrichment cDNA library as the template. The expression profiles of Sj CyPA were determined at several different development stages by using real-time RT-PCR. The cDNA containing the open reading frame (ORF) of CyPA was subcloned into a pET28a(+) vector and the recombinant plasmid was transformed into competent E.coil/BL21 for producing recombinant protein. The PPIase activity of recombinant protein was determined by chymotrypsin-coupled chromogenic assay, and its antigenicity was confirmed by Western blot. The immunoprotective potential immunized by recombinant Sj CyPA in mice was also evaluated in the present study. [ Result ] The length of cDNA containing Sj CyPA ORF is 519 base pairs, encoding 172 amino acids. As determined by real-time PCR, the highest expression of Sj CyPA was observed at the transcript level at 13-day schistosomula stage, indicating that Si CyPA was a abundant expression gene at schistosomula stage. The expressions of Sj CyPA both at transprict level and at protein level were not significantly alternated upon the treatment by cyclosporin A as determined by real time PCR and Western blot. Expectly, chymotrypsin- coupled chromogenic assay confirmed that Sj CyPA had PPIase activity and Western blot indicated that Sj CyPA was able to induce specific antibodies. Additionally, animal experiment showed that 18.72% worm reduction and 44.6% egg reduction were achieved in mice vaccinated with recombinant CyPA protein, respectively. [Conclusion] A full-length cDNA encoding Sj CyPA was obtained and its molecular characterizations were preliminarily investigated. Moreo